4.7 Article

Apolipoprotein E4 effects on topological brain network organization in mild cognitive impairment

Journal

SCIENTIFIC REPORTS
Volume 11, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-020-80909-7

Keywords

-

Funding

  1. National Institute on Aging
  2. National Institute of Biomedical Imaging and Bioengineering
  3. Alzheimer's Association
  4. Alzheimer's Drug Discovery Foundation
  5. Araclon Biotech
  6. Biogen
  7. Bristol-Myers Squibb Company
  8. CereSpir, Inc.
  9. Cogstate
  10. Elan Pharmaceuticals, Inc.
  11. Eli Lilly and Company
  12. EuroImmun
  13. F. Hoffmann-La Roche Ltd
  14. Fujirebio
  15. Johnson & Johnson Pharmaceutical Research & Development LLC.
  16. Meso Scale Diagnostics
  17. NeuroRx Research
  18. Novartis Pharmaceuticals Corporation
  19. Pfizer Inc.
  20. Piramal Imaging
  21. Takeda Pharmaceutical Company
  22. Canadian Institutes of Health Research
  23. ADNI clinical sites in Canada
  24. Foundation for the National Institutes of Health
  25. Northern California Institute for Research and Education
  26. Alzheimer's Therapeutic Research Institute at the University of Southern California
  27. AbbVie
  28. BioClinica, Inc.
  29. Eisai Inc.
  30. F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.
  31. GE Healthcare
  32. IXICO Ltd.
  33. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  34. Johnson & Johnson Pharmaceutical Research & Development LLC
  35. Lumosity
  36. Lundbeck
  37. Merck Co., Inc.
  38. Meso Scale Diagnostics, LLC.
  39. Neurotrack Technologies
  40. Servier
  41. Transition Therapeutics
  42. European Union Seventh Framework Programme (FP7/2007-2013) [604102]
  43. European 'Union's Horizon 2020 research and innovation programme [720270]
  44. MORPHEMIC Grant [871643]
  45. Swiss National Science Foundation [32003B_135679, 32003B_159780, CRSK-3_190185]
  46. Leenaards Foundation
  47. Roger De Spoelberch Foundation
  48. Partridge Foundation
  49. Swiss National Science Foundation (SNF) [CRSK-3_190185, 32003B_159780] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The study found that in Mild Cognitive Impairment stage, patients with the ApoE4 gene exhibit different topological properties in cortical thickness covariance networks compared to non-Carriers, indicating certain differences in the organization of brain networks.
The Apolipoprotein E isoform E4 (ApoE4) is consistently associated with an elevated risk of developing late-onset Alzheimer's Disease (AD); however, less is known about the potential genetic modulation of the brain networks organization during prodromal stages like Mild Cognitive Impairment (MCI). To investigate this issue during this critical stage, we used a dataset with a cross-sectional sample of 253 MCI patients divided into ApoE4-positive ('Carriers') and ApoE4-negative ('non-Carriers'). We estimated the cortical thickness (CT) from high-resolution T1-weighted structural magnetic images to calculate the correlation among anatomical regions across subjects and build the CT covariance networks (CT-Nets). The topological properties of CT-Nets were described through the graph theory approach. Specifically, our results showed a significant decrease in characteristic path length, clustering-index, local efficiency, global connectivity, modularity, and increased global efficiency for Carriers compared to non-Carriers. Overall, we found that ApoE4 in MCI shaped the topological organization of CT-Nets. Our results suggest that in the MCI stage, the ApoE4 disrupting the CT correlation between regions may be due to adaptive mechanisms to sustain the information transmission across distant brain regions to maintain the cognitive and behavioral abilities before the occurrence of the most severe symptoms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available